Learning Objectives:

Head and Neck

1.  Understand the role of pembrolizumab in first line treatment of advanced head & neck cancer patients with metastatic or unresectable disease.

2.  Consider the options of surgical vs. radiation-based approaches to treatment of HPV-related oropharyngeal cancer.

Thoracic:

1.  Learn about immune therapy in lung cancer.

2.  Discuss side effects of immune therapy in lung cancer.

3.  Review options for other therapies in lung cancer.

Session date: 
Thursday, August 29, 2019 - 8:00am to 9:15am
Speaker Name: 
Bruce Brockstein, M.D. & Nick Campbell, M.D.
Location: 
Evanston Hospital, Room G870
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.